N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide

Categorie

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Les marques, N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Analogs

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Les marques melange

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Formule chimique

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide RX lien

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide FDA fiche

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide msds (fiche de securite des materiaux)

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Synthese de reference

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Poids moleculaire

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Point de fusion

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide H₂O Solubilite

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Etat

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide LogP

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Formes pharmaceutiques

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Indication

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Pharmacologie

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Absorption

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Toxicite

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Information pour les patients

N-[1-(4-Bromophenyl)Ethyl]-5-Fluoro Salicylamide Organismes affectes